FinTechFunding

Palla Pharma: Enters sale and leaseback of Coolaroo site

Palla Pharma Enters sale and leaseback of Coolaroo site

  • Palla Pharma (PAL) enters into a sale and leaseback agreement of its $33.1 million manufacturing site in Melbourne
  • Upon receiving funds for the Coolaroo location, the company made a gain of around $21 million
  • Palla retains acess to $5 million of undrawn capacity under its existing credit facility
  • The 18-month lease arrangement, with an option to extend for six months, allows continued site access
  • PallaPharma shares are in the green, up 2.6 per cent, trading at 40 cents at 2:08 pm AEDT
Previous article
Horseshoe Metals: Completes ASX requirements for potential relisting
Next article
Seeded Network: Raises $1.25M in Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

UK Banks Reject Opportunity to Lift £100 Contactless Limit

Major UK banks choose not to increase contactless payment thresholds.Highlights: UK banks will not raise the £100 contactless...
FinTech

Crypto.com Cuts 12% of Workforce Amid AI Shift

The company streamlines operations in response to evolving market dynamics.Highlights: Crypto.com reduces workforce by 12%Focus shifts to AI...
FinTech

Tide Strengthens Leadership with PPRO CTO Appointment

The fintech company welcomes a new chief technology officer to enhance its team.Highlights: Tide appoints ex-PPRO CTO to...
FinTech

Visa Overcomes Legacy Issues with Unified API for Intelligent Authorization

New API aims to streamline payment processes and enhance security features.Highlights: Visa launches a unified API to improve...